January 2025 PMID 39471883

Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort.

Gilbert H L Tang, Rebecca T Hahn, Brian K Whisenant, Nadira Hamid, Hursh Naik, Raj R Makkar, Peter Tadros, Matthew J Price, Gagan D Singh, Neil P Fam, Saibal Kar, Shamir R Mehta, Richard Bae, Nishant K Sekaran, Travis Warner

Full text PDF Download social card

Mentions

Peak: 19 in Oct 2024

across 6 sources since Oct 2024

Extended reach

710,855

potential audience

Total likes

122

Video views

1,740

Mentions per month

Oct 2024 – Mar 2025

Where it's discussed

X / Twitter27 posts
News8 articles
YouTube4 videos
Facebook4 posts
Blogs2 articles
Bluesky1 posts

AI synopsis

What people are saying

Discussions express strong agreement with the study's positive results, using words like 'promising' and 'effective,' while showing high interest in the procedure's benefits. The engagement is demonstrated through references to detailed outcomes like TR severity reduction and quality of life improvements, and the overall tone underscores a belief that these findings could influence future heart treatments.

AgreementModerate agreement

Most discussions support the positive findings of the TRILUMINATE study, emphasizing its safety and effectiveness.

InterestHigh interest

The discussions reflect high curiosity about the new treatment and its implications for heart health, showing enthusiasm for the procedure's advancements.

EngagementModerate engagement

Participants reference specific outcomes like TR reduction, improved quality of life, and technical details, indicating meaningful engagement.

ImpactHigh impact

The conversations highlight the significant potential impact of the study, including FDA approval and changes in treatment approaches.

Abstract in brief

The TRILUMINATE Pivotal trial assessed the effects of tricuspid transcatheter edge-to-edge repair (T-TEER) on reducing tricuspid regurgitation (TR), a significant heart condition linked to increased health risks.
Involving 572 patients, mostly elderly women with prior heart conditions, the trial found that T-TEER effectively improved quality of life, with nearly half of those treated experiencing significant improvements in heart health assessments.
Results showed that while the treatment and control groups had similar rates of survival and heart-related surgeries, those who underwent T-TEER had notably better outcomes in TR severity and overall quality of life.

Read the full abstract

All mentions

Advancements in Tricuspid Regurgitation Treatment via TTVR

In this JACC Journal Club session, we analyze cutting-edge research on tricuspid transcatheter interventions, emphasizing the TRISCEND II trial. Our experts discuss patient selection, procedural techniques, and…

American College of Cardiology · Feb 28, 2025 849 views

Improving Quality of Life with Transcatheter Tricuspid Valve Replacement

In this JACC Masterclass, Aakriti Gupta MD FACC and Martin B Leon MD FACC discuss the impact of severe tricuspid regurgitation on health status and the TRISCEND II trial findings. They highlight significant improvements…

American College of Cardiology · Jan 27, 2025 455 views

One-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation

The TRILUMINATE trial evaluates T-TEER's impact on severe tricuspid regurgitation. Results show improved quality of life and reduced TR severity after one year, with no significant difference in mortality or additional…

American College of Cardiology · Oct 29, 2024 408 views

Efficacy of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation

The TRILUMINATE trial evaluated the impact of T-TEER on reducing tricuspid regurgitation and improving patient quality of life, showing significant benefits in heart health and symptom relief for elderly patients with…

Medical Portfolio APP · Jan 14, 2025 29 views

Northwestern Surgery

@NMSurgery · X

RT @NMCardioVasc:

Mar 26, 2025 · 1 share · 3,501 followers View post →

NM Cardiovascular

@NMCardioVasc · X

Mar 25, 2025 · 7 likes · 1 share · 4,633 followers View post →

NM Cardiovascular

@nmcardiovasc.bsky.social · Bluesky

Mar 25, 2025 · 1 like View post →

Heart News

@HearttNews · X

The TRILUMINATE study shows promising 1-year outcomes for patients with severe tricuspid regurgitation using transcatheter edge-to-edge repair. #HeartHealth #MedicalResearch https://t.co/Af5IUV9xZ6 https://t.co/XPiT7u5734

Mar 25, 2025 · 8 followers View post →

Shubha Pawar

@ShubhaPawar · X

RT @JACCJournals: (11/13) For more on the revolution in structural cardiology, check out #JACC Executive Associate Editor Dr. @aakriti_15's…

Mar 5, 2025 · 2 shares · 31 followers View post →

Ordo Fraterna Fibonacci

@OrdoFibonacci · X

Transcatheter Interventions for Tricuspid Regurgitation | JACC Journal Club American College of Cardiology https://t.co/HmjMGawBvk

Mar 1, 2025 · 2,555 followers View post →

フロシンキ

@hurosinki · X

TRILUMINATE(および心臓リモデリングを評価したサブ解析)やTRISCEND IIも紹介されてます https://t.co/zl56nZ3eo9 https://t.co/u93QSO57e9 https://t.co/sZ2YhGmdXQ

Jan 22, 2025 · 329 followers View post →

Aakriti Gupta, MD MSc

@aakriti_15 · X

RT @JACCJournals: (11/13) For more on the revolution in structural cardiology, check out #JACC Executive Associate Editor Dr. @aakriti_15's…

Jan 21, 2025 · 2 shares · 2,441 followers View post →

JACC Journals

@JACCJournals · X

Jan 21, 2025 · 10 likes · 2 shares · 114,176 followers View post →

JACC Journals

@JACCJournals · X

Jan 21, 2025 · 5 likes · 114,412 followers View post →

Osama Bisht

@Obisht · X

RT @JACCJournals: #TCT2024 ICYMI: #JACC AE Dr. Celina Yong from @StanfordDeptMed talks with #JACCCaseReports EiC Dr. @GilbertTangMD about t…

Oct 31, 2024 · 2 shares · 6,404 followers View post →

JACC Journals

@JACCJournals · X

#TCT2024 ICYMI: #JACC AE Dr. Celina Yong from @StanfordDeptMed talks with #JACCCaseReports EiC Dr. @GilbertTangMD about the full results of the #TRILUMINATE pivotal trial

Oct 31, 2024 · 11 likes · 2 shares · 114,412 followers View post →

Victor G. Aldana

@vgaldana · X

RT @JACCJournals: #TCT2024: T-TEER was approved by @US_FDA for #TricuspidRegurgitation in 2024 based on interim results of #TRILUMINATE. Fu…

Oct 27, 2024 · 9 shares · 670 followers View post →

Yoichiro.S@循環器内科医

@cardio_dr_ys · X

RT @JACCJournals: #TCT2024: T-TEER was approved by @US_FDA for #TricuspidRegurgitation in 2024 based on interim results of #TRILUMINATE. Fu…

Oct 27, 2024 · 9 shares · 3,422 followers View post →

Hany Ragy

@Hragy · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 80,357 followers View post →

Eike Tigges

@EPTIG · X

RT @JACCJournals: #TCT2024: T-TEER was approved by @US_FDA for #TricuspidRegurgitation in 2024 based on interim results of #TRILUMINATE. Fu…

Oct 27, 2024 · 9 shares · 479 followers View post →

Wael Metwally Elsayed

@wisevision2010 · X

RT @JACCJournals: #TCT2024: T-TEER was approved by @US_FDA for #TricuspidRegurgitation in 2024 based on interim results of #TRILUMINATE. Fu…

Oct 27, 2024 · 9 shares · 172 followers View post →

JACC Journals

@JACCJournals · X

Oct 27, 2024 · 29 likes · 9 shares · 114,412 followers View post →

SleepyAndHungryCardiologyFellow

@tryinghard13498 · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 8 followers View post →

Joanna Bartkowiak

@joan_bartc · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 69 followers View post →

Hooman Bakhshi

@BakhshiHooman · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 6,778 followers View post →

Gino Gomez

@gino1087 · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 1,066 followers View post →

Shikha Jha MD, CPPS, CPHQ

@Shikha_Cardio · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 4,092 followers View post →

Moaaz Elsharabassy

@melsharabasssy · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 696 followers View post →

Steven Mathern

@StevenMathern · X

Triclip T-TEER TR 'Tricuspid transcatheter edge-to-edge repair for severe tricuspid regurgitation' TEER https://t.co/cAE83rjSer

Oct 27, 2024 · 1 like · 457 followers View post →

Yoichiro.S@循環器内科医

@cardio_dr_ys · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 3,422 followers View post →

RTHahnMD

@hahn_rt · X

RT @JACCJournals: #TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub…

Oct 27, 2024 · 19 shares · 15,208 followers View post →

JACC Journals

@JACCJournals · X

Oct 27, 2024 · 58 likes · 19 shares · 114,412 followers View post →

Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

Advancements in Tricuspid Regurgitation Treatment via TTVR

Improving Quality of Life with Transcatheter Tricuspid Valve Replacement

One-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation

Efficacy of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation